-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Syndax Pharmaceuticals Inc annual Depreciation history and growth rate from 2014 to 2023.
- Syndax Pharmaceuticals Inc annual Depreciation for 2023 was $12M, a 63.6% decline from 2022.
- Syndax Pharmaceuticals Inc annual Depreciation for 2022 was $33M, a 23.3% decline from 2021.
- Syndax Pharmaceuticals Inc annual Depreciation for 2021 was $43M, a 47678% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)